317 related articles for article (PubMed ID: 33461918)
1. New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic.
Seghatchian J
Transfus Apher Sci; 2021 Feb; 60(1):103051. PubMed ID: 33461918
[No Abstract] [Full Text] [Related]
2. Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.
Garraud O; Burnouf T
Transfus Clin Biol; 2021 Aug; 28(3):225-227. PubMed ID: 34362557
[No Abstract] [Full Text] [Related]
3. Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.
Hassan M; Zalkifal M; Wahab A; Afzal S; Rafique S; Shahid M; Khan MA; Ahmed N; Idrees M; Shahid AA
Crit Rev Eukaryot Gene Expr; 2021; 31(3):21-34. PubMed ID: 34369712
[TBL] [Abstract][Full Text] [Related]
4. Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the United States.
Hassan S; West KA; Conry-Cantilena K; De Giorgi V
Transfusion; 2022 Feb; 62(2):483-492. PubMed ID: 34778974
[No Abstract] [Full Text] [Related]
5. COVID-19 Pandemic and Virtual Clinics for Diabetes Care.
Garg SK; Reinicke T
Diabetes Technol Ther; 2021 Jun; 23(S2):S3-S15. PubMed ID: 34061640
[No Abstract] [Full Text] [Related]
6. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
Majumder J; Minko T
AAPS J; 2021 Jan; 23(1):14. PubMed ID: 33400058
[TBL] [Abstract][Full Text] [Related]
7. Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants.
Raturi M; Kusum A; Kala M; Mittal G; Sharma A; Bansal N
Transfus Clin Biol; 2021 Aug; 28(3):300-302. PubMed ID: 33971318
[TBL] [Abstract][Full Text] [Related]
8. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW
Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines.
Iqbal Yatoo M; Hamid Z; Parray OR; Wani AH; Ul Haq A; Saxena A; Patel SK; Pathak M; Tiwari R; Malik YS; Sah R; Rabaan AA; Rodriguez Morales AJ; Dhama K
Hum Vaccin Immunother; 2020 Dec; 16(12):2891-2904. PubMed ID: 32703064
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and Dialysis Patients: Unsolved Problems in Early 2021.
Kliger AS; Silberzweig J
J Am Soc Nephrol; 2021 May; 32(5):1018-1020. PubMed ID: 33637517
[No Abstract] [Full Text] [Related]
11. Experience with COVID-19 convalescent plasma provides vital guidance to future pandemics.
Hartmann J; Bloch EM; Burnouf T
Transfusion; 2022 Mar; 62(3):681-684. PubMed ID: 35098540
[No Abstract] [Full Text] [Related]
12. [Value of convalescent plasma in the therapy of COVID-19].
Körper S; Seifried E; Schrezenmeier H
Dtsch Med Wochenschr; 2023 Mar; 148(7):423-426. PubMed ID: 36940693
[TBL] [Abstract][Full Text] [Related]
13. Fast-spreading COVID variant can elude immune responses.
Callaway E
Nature; 2021 Jan; 589(7843):500-501. PubMed ID: 33479534
[No Abstract] [Full Text] [Related]
14. A look-back at convalescent plasma to treat COVID-19.
Garraud O; Lacombe K; Tiberghien P
Transfus Apher Sci; 2021 Feb; 60(1):103063. PubMed ID: 33478889
[No Abstract] [Full Text] [Related]
15. COVID-19 convalescent plasma: current status, lessons from the past and future perspectives.
Hervig TA; Flesland Ø; Nissen-Meyer LSH
Transfus Apher Sci; 2022 Aug; 61(4):103487. PubMed ID: 35778352
[TBL] [Abstract][Full Text] [Related]
16. Donating convalescent plasma for COVID-19 patients.
Black E
Br Dent J; 2020 Nov; 229(10):643. PubMed ID: 33247247
[No Abstract] [Full Text] [Related]
17. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
Sewell HF; Agius RM; Kendrick D; Stewart M
BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
[No Abstract] [Full Text] [Related]
18. Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India.
Bansal N; Raturi M; Bansal Y
Transfus Clin Biol; 2021 Aug; 28(3):296-298. PubMed ID: 34102319
[No Abstract] [Full Text] [Related]
19. Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
Mehew J; Johnson R; Roberts D; Griffiths A; Harvala H
Transfus Med; 2022 Aug; 32(4):327-337. PubMed ID: 35434868
[TBL] [Abstract][Full Text] [Related]
20. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.
Vandeberg P; Cruz M; Diez JM; Merritt WK; Santos B; Trukawinski S; Wellhouse A; Jose M; Willis T
Transfusion; 2021 Jun; 61(6):1705-1709. PubMed ID: 33715160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
